These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21964782)

  • 41. Synthetic affinity ligands as a novel tool to improve protein stability.
    Sousa IT; Ruiu L; Lowe CR; Taipa MA
    J Mol Recognit; 2009; 22(2):83-90. PubMed ID: 18654989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A native chemical ligation approach for combinatorial assembly of affibody molecules.
    Lindgren J; Ekblad C; Abrahmsén L; Eriksson Karlström A
    Chembiochem; 2012 May; 13(7):1024-31. PubMed ID: 22532524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein purification by aminosquarylium cyanine dye-affinity chromatography.
    Graça VC; Sousa F; Santos PF; Almeida PS
    Methods Mol Biol; 2015; 1286():23-33. PubMed ID: 25749942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved anti-IgG and HSA affinity ligands: clinical application of VHH antibody technology.
    Klooster R; Maassen BT; Stam JC; Hermans PW; Ten Haaft MR; Detmers FJ; de Haard HJ; Post JA; Theo Verrips C
    J Immunol Methods; 2007 Jul; 324(1-2):1-12. PubMed ID: 17570391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design of screening collections for successful fragment-based lead discovery.
    Na J; Hu Q
    Methods Mol Biol; 2011; 685():219-40. PubMed ID: 20981526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A synthetic ligand for IgA affinity purification.
    Palombo G; De Falco S; Tortora M; Cassani G; Fassina G
    J Mol Recognit; 1998; 11(1-6):243-6. PubMed ID: 10076848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Separation of antigens and antibodies by immunoaffinity chromatography.
    Sheng S; Kong F
    Pharm Biol; 2012 Aug; 50(8):1038-44. PubMed ID: 22480305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Designed affinity ligands to capture human serum albumin.
    Dos Santos R; Figueiredo C; Viecinski AC; Pina AS; Barbosa AJM; Roque ACA
    J Chromatogr A; 2019 Jan; 1583():88-97. PubMed ID: 30502038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combinatorial de novo design and application of a biomimetic affinity ligand for the purification of human anti-HIV mAb 4E10 from transgenic tobacco.
    Platis D; Maltezos A; Ma JK; Labrou NE
    J Mol Recognit; 2009; 22(6):415-24. PubMed ID: 19431140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2,4,6-trisubstituted triazines as protein a mimetics for the treatment of autoimmune diseases.
    Zacharie B; Abbott SD; Bienvenu JF; Cameron AD; Cloutier J; Duceppe JS; Ezzitouni A; Fortin D; Houde K; Lauzon C; Moreau N; Perron V; Wilb N; Asselin M; Doucet A; Fafard ME; Gaudreau D; Grouix B; Sarra-Bournet F; St-Amant N; Gagnon L; Penney CL
    J Med Chem; 2010 Feb; 53(3):1138-45. PubMed ID: 20047277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleotide-mimetic synthetic ligands for DNA-recognizing enzymes One-step purification of Pfu DNA polymerase.
    Melissis S; Labrou NE; Clonis YD
    J Chromatogr A; 2006 Jul; 1122(1-2):63-75. PubMed ID: 16712859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Bead blot: a method for identifying ligand-protein and protein-protein interactions using combinatorial libraries of peptide ligands.
    Lathrop JT; Fijalkowska I; Hammond D
    Anal Biochem; 2007 Feb; 361(1):65-76. PubMed ID: 17188224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody purification by affinity chromatography based on small molecule affinity ligands identified by SPR-based screening of chemical microarrays.
    Arnold M; Bittermann H; Kalbfuss-Zimmermann B; Neumann T; Schmidt K; Sekul R; Hilbrig F; Ludolph H; Freitag R
    J Chromatogr A; 2011 Jul; 1218(29):4649-59. PubMed ID: 21683366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fragment-based approaches and computer-aided drug discovery.
    Rognan D
    Top Curr Chem; 2012; 317():201-22. PubMed ID: 21710380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and assessment of a de novo affinity adsorbent for the purification of recombinant human erythropoietin.
    El Khoury G; Wang Y; Wang D; Jacob SI; Lowe CR
    Biotechnol Bioeng; 2013 Nov; 110(11):3063-9. PubMed ID: 23613257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrating structure-based and ligand-based approaches for computational drug design.
    Wilson GL; Lill MA
    Future Med Chem; 2011 Apr; 3(6):735-50. PubMed ID: 21554079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microarrays of tagged combinatorial triazine libraries in the discovery of small-molecule ligands of human IgG.
    Uttamchandani M; Walsh DP; Khersonsky SM; Huang X; Yao SQ; Chang YT
    J Comb Chem; 2004; 6(6):862-8. PubMed ID: 15530111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combinatorial and computational approaches in structure-based drug design.
    Kubinyi H
    Curr Opin Drug Discov Devel; 1998 Jul; 1(1):16-27. PubMed ID: 19649785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.